Connect with us

National

Naphthalene-based PLpro inhibitors could work as COVID-19 therapeutics – Drug Target Review

Naphthalene-based PLpro inhibitors have been shown to block the activity of a SARS-CoV-2 protein, demonstrating potential as COVID-19 therapeutics.

Published

on

post featured image